Table 1

Priority pediatric ARV formulations

Pediatric ARV

Dosage Form

2007 WHO

Recommendation

Ideal Dosage

Form

Produced and

purchased

2009 WHO

Recommendation


3TC30/NVP50/ZDV60

Urgent

yes

yes

yes


3TC30/NVP60/ZDV60

Urgent


3TC75/NVP100/ZDV150

Urgent


3TC30/ZDV60

Urgent

yes

yes

yes


3TC75/ZDV150

Urgent


3TC30/d4T6

Urgent

yes

yes

yes


3TC75/d4T15

Urgent


3TC30/NVP50/d4T6

Urgent

yes

yes

yes


3TC20/NVP35/d4T5

Urgent

yes


3TC30/NVP50/d4T7

Urgent


3TC60/NVP100/d4T12

Urgent

yes


3TC40/NVP70/d4T10

Urgent

yes


NVP 50

Urgent

yes

yes


NVP 100

Urgent


LPV100/r25

Urgent

yes

yes

yes


LPV90/r22.5

Urgent


ABC 60

Urgent

yes

yes

yes


ABC 120

Urgent


ABC 150

Urgent


EFV 100

High

yes

yes

yes


EFV 600

High

yes


ABC60/3TC30

High

yes

yes

yes


ABC150/3TC75

High


ZDV 60

High

yes

yes


ZDV 100

High

yes


ABC60/3TC30/ZDV60

High

yes

yes


ABC150/3TC75/ZDV150

High


d4T 6

High

yes

yes


d4T 15

High


ddI 125

Important

yes


ddI 200

Important

yes


3TC 30

Important

yes

yes


3TC 75

Important


3TC 150

Important

yes


EFV100/FTC35

Important

yes

yes


FTC 35

Important

yes

yes


RTV 25

Important

yes

yes


RTV 100

Important


FPV*

Important

yes

yes


DRV*

Important


ABC60/NVP50/ZDV60

yes


ATV*

yes


*dose to be determined

Waning et al. BMC Pediatrics 2010 10:74   doi:10.1186/1471-2431-10-74

Open Data